Overview

Dasotraline Adult ADHD Study

Status:
Completed

Trial end date:
2016-09-01

Target enrollment:

Participant gender:

Summary

This is a randomized, double blind, multicenter, parallel group, outpatient study evaluating the efficacy and safety of dasotraline in adults with ADHD.

Phase:

Phase 3

Details

Lead Sponsor:

Sunovion